Management and outcomes of patients with isolated superficial vein thrombosis under real life conditions (INSIGHTS-SVT)

      Although 30% of the patients had received anticoagulation therapy for isolated superficial vein thrombosis (SVT), the risk of recurrent or extension of the SVT was increased.
      To read this article in full you will need to make a payment
      SVS Member Login
      Society Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect